Recent reports suggest that Miami Marlins ace Sandy Alcántara may be on the trading block, with insiders predicting a potential move before the trade deadline. Alcántara, who underwent Tommy John surgery in October 2023 and missed the entire 2024 season, has shown promising signs in his 2025 spring training appearances, pitching 5.2 innings with five strikeouts and no earned runs.
The New York Mets are among the teams reportedly interested in acquiring Alcántara. This interest is heightened by the Mets’ current pitching challenges, notably the indefinite shutdown of right-hander Frankie Montas due to a severe lat strain.
The potential addition of Alcántara could provide the Mets with the ace they need to solidify their rotation.
However, trades within the same division are uncommon, and the Mets must weigh the cost of acquiring Alcántara against their long-term strategy. Given Alcántara’s previous performance, including his 2022 National League Cy Young Award, and his team-friendly contract—$17 million annually through 2026 with a $21 million club option for 2027—interest from multiple teams is expected.
As the trade deadline approaches, the Mets face a crucial decision: pursue Alcántara to bolster their rotation or explore alternative options. Their choice will significantly impact their competitiveness in the upcoming season.